Cargando…

First person – Matt Johansen

First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Matt Johansen is first author on ‘ Mycobacteriophage–antibiotic therapy promotes enhanced c...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461819/
http://dx.doi.org/10.1242/dmm.049238
_version_ 1784572069305909248
collection PubMed
description First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Matt Johansen is first author on ‘ Mycobacteriophage–antibiotic therapy promotes enhanced clearance of drug-resistant Mycobacterium abscessus’, published in DMM. Matt completed the research described in this article while a postdoc in the lab of Laurent Kremer at Institut de Recherche en Infectiologie de Montpellier, Montpellier, France, and is now a postdoc in the lab of Phil Hansbro at the Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia, investigating the disease pathogenesis of infectious organisms and deciphering host–pathogen interactions.
format Online
Article
Text
id pubmed-8461819
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-84618192021-09-24 First person – Matt Johansen Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Matt Johansen is first author on ‘ Mycobacteriophage–antibiotic therapy promotes enhanced clearance of drug-resistant Mycobacterium abscessus’, published in DMM. Matt completed the research described in this article while a postdoc in the lab of Laurent Kremer at Institut de Recherche en Infectiologie de Montpellier, Montpellier, France, and is now a postdoc in the lab of Phil Hansbro at the Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia, investigating the disease pathogenesis of infectious organisms and deciphering host–pathogen interactions. The Company of Biologists Ltd 2021-09-17 /pmc/articles/PMC8461819/ http://dx.doi.org/10.1242/dmm.049238 Text en © 2021. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle First Person
First person – Matt Johansen
title First person – Matt Johansen
title_full First person – Matt Johansen
title_fullStr First person – Matt Johansen
title_full_unstemmed First person – Matt Johansen
title_short First person – Matt Johansen
title_sort first person – matt johansen
topic First Person
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461819/
http://dx.doi.org/10.1242/dmm.049238